NewLink Genetics Announces Participation at The H.C. Wainwright Annual Global Life Sciences Conference
If you are an institutional investor, and would like to attend the Company’s presentation, please click on the following link (www.hcwevents.com) to register for the conference. Once your registration is confirmed, you will be prompted to log into the conference website to request a one-on-one meeting with the Company.
A live webcast of the conference presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events & Presentations.”
About NewLink Genetics Corporation
NewLink Genetics is a late-stage biopharmaceutical company focusing on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer.
Director of Investor Relations
617-374-8800, ext. 105
Source: NewLink Genetics Corporation